Accéder au contenu
Merck

An in vitro synthetic biology platform for the industrial biomanufacturing of myo-inositol from starch.

Biotechnology and bioengineering (2017-04-15)
Chun You, Ting Shi, Yunjie Li, Pingping Han, Xigui Zhou, Yi-Heng Percival Zhang
RÉSUMÉ

Myo-Inositol (vitamin B8) is widely used in the drug, cosmetic, and food & feed industries. Here, we present an in vitro non-fermentative enzymatic pathway that converts starch to inositol in one vessel. This in vitro pathway is comprised of four enzymes that operate without ATP or NAD

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Zinc isopropylsulfinate, 95%